Approval · Notice of Compliance 56 · 2003
PROLEUKIN: Notice of Compliance 56
Issued August 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 56
- Date
- August 11, 2003
- Company
- Chiron Canada Limited
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Regulatory relief from in-process and final product release testing and modifications to lot release protocol
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | Not yet assigned | — |
Medicinal ingredients
- ALDESLEUKIN 22,000,000 UNIT per VIAL